加强数字健康创新中的患者与公众参与:MyRA 应用开发与真实世界测试的反思性分析
本研究采用多方法定性途径,回顾分析焦点小组、共创会议、研究后问卷及指导小组会议记录,考察患者与公众参与如何嵌入面向类风湿关节炎患者的 MyRA 自我监测应用的开发与真实世界测试。患者研究伙伴与经验专家全程参与并影响关键设计决策,整体与 EULAR 患者研究伙伴参与推荐一致,但参与模式与偏好存在差异。持续参与可强化数字健康创新,但需更广泛用户验证、管理不同利益相关者期望并建立清晰协作结构。
要点
- 患者研究伙伴与经验专家全程参与 MyRA 开发并影响关键设计决策。
- 参与整体符合 EULAR 患者研究伙伴推荐,但协作有时复杂。
- 持续参与需更广泛用户验证、管理不同期望并建立清晰协作结构。
核心结论
- 在应用开发各阶段持续嵌入患者与公众参与可强化数字健康创新,但需配套更广泛用户验证、利益相关者期望管理与清晰协作结构。
研究设计与样本
- 采用多方法定性途径,回顾性分析焦点小组与共创会议文件、研究后问卷、指导小组会议记录及反思性指导小组会议,并用归纳与演绎分析对全部发现进行综合与三角验证。
主要发现
- 患者研究伙伴与经验专家全程参与项目并影响关键设计决策。
- 研究后问卷显示既有积极体验也有挑战,包括参与模式与对应用功能偏好的差异。
- 患者研究伙伴参与整体与 EULAR 推荐一致,协作被认为有价值但有时复杂。
- 上述见解形成了一套面向数字健康研究中患者与公众有意义参与的实践导向考量。
关键数值与推荐
- 患者研究伙伴参与整体与 EULAR 关于患者研究伙伴参与研究的推荐一致。
临床怎么用
- 在数字健康应用的迭代开发与真实世界测试中,应全程嵌入患者与公众参与,并超越核心小组开展更广泛用户验证。
- 需管理不同利益相关者的视角与期望,并建立清晰的协作结构以支撑有意义的参与。
- 可将本研究形成的实践导向考量用于调整患者与公众参与框架,以适应快速迭代的数字健康情境。
局限性
- 原文摘要未报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: To ensure that digital health applications reflect real-world needs and preferences, meaningful public and patient involvement is essential throughout the design process. However, existing patient and public involvement frameworks often fall short in guiding the fast-paced, iterative nature of digital health innovations. This study aimed to examine how patient and public involvement was embedded in the development and real-world testing of MyRA, a web-based self-monitoring application designed for and with people with rheumatoid arthritis, and explored the impact of this involvement. METHODS: We used a multimethod, qualitative approach with retrospective analysis of multiple data sources. Documents from focus groups and co-creation sessions were used to examine the timing, form, and influence of patient and public involvement on design. A post-study questionnaire captured real-world experiences with MyRA. Steering group meeting notes assessed alignment with European Alliance of Associations for Rheumatology (EULAR) recommendations for involvement of patient research partners in research. Reflective steering group meetings provided further insights. All findings were synthesised and triangulated using inductive and deductive analyses. FINDINGS: Patient research partners and experts by experience were involved throughout the project and influenced key design decisions. The post-study questionnaire revealed both positive experiences and challenges, including varied engagement patterns and preferences for application features. Overall, involvement of patient research partners in the project aligned well with the EULAR recommendations, and collaboration was seen as valuable, although sometimes complex. These insights informed a set of practice-informed considerations for meaningful patient and public involvement in digital health research. INTERPRETATION: Continuous patient and public involvement across application development phases can strengthen digital health innovation but requires broader user validation beyond a core group, managing different stakeholder perspectives and expectations, and ensuring clear structures for collaboration. The findings offer practical considerations to tailor patient and public involvement frameworks for use in iterative, fast-moving digital health contexts. FUNDING: Health Holland.
引用
- Hochstenbach LMJ, Verbeek JGE, Bakker MM, et al. Strengthening patient and public involvement in digital health innovation: reflective analysis of the development and real-world testing of the MyRA application. Lancet Rheumatol. 2026. PMID: 41579875. doi:10.1016/S2665-9913(25)00341-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。